The Swiss Tropical and Public Health Institute is at the forefront of important research using Volumetric Absorptive Microsampling (VAMS®) technology and Mitra® microsampling devices in low-resourced regions. Recently, it tested Mitra® devices against more traditional Dried Blood Spot (DBS) cards in pediatric PK studies in rural Côte d’Ivoire.
In an era of change, labs are responding with new and innovative approaches and considering new angles from science and business perspectives. One Austin-based lab, focused on personalized medicine, merits special attention.
Laboratories: It’s time to get off the reimbursement treadmill.
You’ll expand your test menu and open your options when you add remote biofluid collection to your toolkit.
At Neoteryx, we research, develop, and commercialize simple, economical, and convenient microsampling devices for the collection and transportation of blood and other biological fluids.
In its May 2018 recommendation, the Food and Drug Administration includes the use of dried blood spot sampling for biomedical validation. The future of clinical chemistry and pharmacology will emphasize the use of microsampling.
The healthcare industry has witnessed drastic changes and will continue experiencing more, due to technology advances and healthcare expectations. These changes provide new opportunities for smart healthcare investors.
Topics: Smarter Healthcare
Capillary blood microsampling is a simple procedure that allows participants to draw their own blood in small, precise, useful amounts. This makes it easy to collect samples anywhere, which opens the door for a host of innovations in consumer health and wellness.